Beam Therapeutics Inc (BEAM)
25.03
-0.67
(-2.61%)
USD |
NASDAQ |
Apr 16, 09:41
Beam Therapeutics Revenue (TTM): 377.71M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 377.71M |
| September 30, 2023 | 81.55M |
| June 30, 2023 | 80.16M |
| March 31, 2023 | 76.70M |
| December 31, 2022 | 60.92M |
| September 30, 2022 | 91.95M |
| June 30, 2022 | 76.92M |
| March 31, 2022 | 60.27M |
| Date | Value |
|---|---|
| December 31, 2021 | 51.84M |
| September 30, 2021 | 0.781M |
| June 30, 2021 | 0.024M |
| March 31, 2021 | 0.024M |
| December 31, 2020 | 0.024M |
| September 30, 2020 | 0.024M |
| June 30, 2020 | 0.024M |
| March 31, 2020 | 0.024M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.024M
Minimum
Mar 2020
377.71M
Maximum
Dec 2023
59.93M
Average
56.06M
Median
Revenue (TTM) Benchmarks
| Eli Lilly and Co | 34.12B |
| Moderna Inc | 6.754B |
| Pfizer Inc | 58.50B |
| Editas Medicine Inc | 78.12M |
| Intellia Therapeutics Inc | 36.28M |